AHA Coding Clinic® for HCPCS - 2018 Quarter 3; For Your Information
New HCPCS code for drugs and biologicals
New HCPCS codes for the reporting of drugs and biologicals became effective for dates of service on or after October 1, 2018. The new HCPCS codes are listed in the table below. HCPCS Code Long Descriptor Q5108 Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg Q5110 Injection, filgrastim-aafi, biosimilar (Nivestym), 1 microgram ...
Subscribe or sign in to view the full article.
Article Overview
This short article covers a set of new HCPCS reporting codes for drugs and biologicals that became effective for dates of service on or after October 1, 2018. It is relevant to coders, billers, and reimbursement staff who track HCPCS updates and need to monitor newly introduced biological and drug-related code additions.
Why This Topic Matters
Articles like this help coding professionals stay current with HCPCS updates affecting drug and biological reporting and claims processing. The article is useful for anyone maintaining charge capture, claim edits, or code lookup resources tied to effective-date changes.
What You Will Learn
- Which HCPCS update category the article addresses
- When the new reporting codes became effective
- Which newly listed drug and biological HCPCS identifiers are included in the update
- How the article frames the update for coding and billing reference use
Who Should Read This
- Medical coders
- Medical billers
- Revenue cycle staff
- Compliance teams
- Coding educators
Codes Discussed
Subscribe or sign in to view the full article.

Quick, Current, Complete - www.findacode.com